Inventor
Christoph Lengauer
Inventor
Columbia, MD, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms35%
G01NInvestigating or analysing materials by determining their chemical or physical properties35%
C12NMicroorganisms or enzymes13%
A61KPreparations for medical, dental or toiletry purposes9%
C07KPeptides9%
PatentTitleYear
10,875,930PIK3C2G fusions202010,669,590PIK3CA fusions202010,407,509NTRK2 fusions20197,354,703'Securin is required for chromosomal stability in human cells'20087,148,009'Cancer drug screen based on cell cycle uncoupling'20066,511,818'Cancer drug screen based on cell cycle uncoupling'20035,888,735'Cancer drug screen based on cell cycle uncoupling'19995,882,865'Cancer drug screen based on cell cycle uncoupling'19995,879,889'Cancer drug screen based on cell cycle upcoupling'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2008Patents assigned to UNIV JOHNS HOPKINS (6)· patent assignee history
1999–2008Based in Columbia, MD, US· patent location history
2019–2020Patents assigned to BLUEPRINT MEDICINES CORP (3)· patent assignee history
2019–2020Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JOHNS HOPKINS | 6 | 1999–2008 |
| BLUEPRINT MEDICINES CORP | 3 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Columbia, Maryland, US | 6 | 1999–2008 |
| Cambridge, Massachusetts, US | 3 | 2019–2020 |